EIEllen C. Ingolfsland

Ellen C. Ingolfsland

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ellen C. Ingolfsland has a total of 40 co-authors. Here are the top co-authors by number of shared publications:

  • Michael K. Georgieff

    Department of Pediatrics, Division of Neonatology, University of Minnesota Medical School, Minneapolis, USA

    3 shared publications
  • Amelia Morikuni

    Department of Pediatrics, Division of Neonatology, University of Minnesota Medical School, Minneapolis, USA

    2 shared publications
  • Ann Kvant

    M Health Fairview, Minneapolis, USA

    2 shared publications
  • Betsy Smith

    M Health Fairview, Minneapolis, USA

    2 shared publications
  • Haeyeon Lee

    Department of Pediatrics, Division of Neonatology, University of Minnesota Medical School, Minneapolis, USA

    2 shared publications
  • Hawa M. Ali

    University of Minnesota Medical School, Minneapolis, USA

    2 shared publications

Latest Publications

  • Semi-automated quantification of total and avascular retinal area in the rat model of oxygen-induced retinopathy

    by Husaam Qureishy, Amelia Morikuni, Michael D. Evans, Rehan Krishnan, Ellen C. Ingolfsland

  • Open Access

    Anemia and retinopathy of prematurity: A narrative review

    by Minali Prasad, David Dombrovsky, Stephen P. Christiansen, Ellen C. Ingolfsland

    Retinopathy of prematurity (ROP) and anemia are often comorbid in preterm and low birth weight infants in the United States. However, the relationship between ROP and anemia in infants is unclear across prospective and retrospective studies due to confounding from other comorbidities of prematurity and variable study designs. Molecular mechanisms that may underlie this association include tissue hypoxia, oxidative stress, inflammation, and the timing of onset of anemia relative to the phase of ROP. Furthermore, maternal or neonatal disruptions in iron homeostasis, leading to either iron deficiency or accumulation, have been associated with ROP. Further studies, including randomized clinical trials, are needed to better elucidate the association between ROP and anemia, as well as the impact of the timing of the onset of anemia.


  • ECI biocommentary

    by Ellen C. Ingolfsland

  • Phlebotomy-induced anemia reduces oxygen-induced retinopathy severity and dampens retinal developmental transcriptomic pathways in rats

    by Ellen C. Ingolfsland, Mandkhai Molomjamts, Ann Foster, Haeyeon Lee, Heidi Roehrich, Amelia Morikuni, Husaam Qureishy, Phu V. Tran, Linda K. McLoon, Michael K. Georgieff

    Background Phlebotomy-induced-anemia (PIA), which induces tissue hypoxia and angiogenesis, occurs universally among infants at risk for severe retinopathy of prematurity (ROP). We hypothesized that PIA exacerbates pathologic retinal neovascularization in ROP. Methods We induced PIA to a hematocrit of 18% among rats undergoing the established 50/10 oxygen-induced retinopathy (OIR) model. Rats were euthanized at P15 and P20, during the avascular and neovascular phases of OIR, respectively. Retinal vascular morphometry, cytokine/chemokine concentrations, transcriptomes, and mRNA expression of angiogenic and iron-deficiency markers were compared to non-PIA controls. Results In OIR, PIA decreased percent avascular area at P15 by 35%, percent neovascular area at P20 by 42%, and select pro-inflammatory cytokine/chemokine concentrations at both time points. At P20, PIA increased mRNA expression of angiopoietin 2/ vascular endothelial growth factor-A 2-fold and transferrin and transferrin receptor 5-fold. RNA sequencing showed dampened pathways of angiogenesis, inflammation, and neural development in anemic OIR females. Conclusion Contrary to our hypothesis, PIA decreased OIR severity and retinal cytokine and chemokine levels and dampened transcriptomic pathways central to retinal vascular and neural development in neonatal rats. These data suggest PIA provides a protective effect from OIR. Further investigation into the functional effect of these molecular changes is warranted. Impact This is the first preclinical study to investigate the impact of neonatal anemia on oxygen-induced retinopathy (OIR) outcomes. This study adds to the literature that anemia decreases neovascularization, decreases cytokine and chemokine levels, and dampens angiogenic and neural transcriptomic pathways in the rat 50/10 OIR model. The study identifies a sex-specific transcriptomic response to anemia in the 50/10 OIR model, with females primarily impacted.


  • Differences in Oxygen-Induced Retinopathy Susceptibility Between Two Sprague Dawley Rat Vendors: A Comparison of Retinal Transcriptomes

    by Haeyeon Lee, Mandkhai Molomjamts, Heidi Roehrich, Sydney Gudvangen, Chanel Asuncion, Michael K. Georgieff, Phu Tran, Linda K. McLoon, Ellen C. Ingolfsland

    PurposeTo determine the retinal transcriptomic differences underlying the oxygen-induced retinopathy phenotypes between Sprague Dawley rat pups from two commonly used commercial vendors. This will allow us to discover genes and pathways that may be related to differences in disease severity in similarly aged premature babies and suggest possible new treatment approaches. MethodsWe analyzed retinal vascular morphometry and transcriptomes from Sprague Dawley rat pups from Charles River Laboratories and Envigo (previously Harlan). Room air control and oxygen-induced retinopathy groups were compared. Oxygen-induced retinopathy was induced with the rat 50/10 model. ResultsPups from Charles River Laboratories developed a more severe oxygen-induced retinopathy phenotype, with 3.6-fold larger percent avascular area at P15 and twofold larger % neovascular area at P20 than pups from Envigo. Changes in retinal transcriptomes of rat pups from both vendors were substantial at baseline and in response to oxygen-induced retinopathy. Baseline differences centered on activated pathways of neuronal development in Charles River Laboratories pups. In response to oxygen-induced retinopathy, during the neovascular phase, retinas from Charles River Laboratories pups exhibited activation of pathways regulating necrosis, neuroinflammation, and interferon signaling, supporting the observed increase of neovascularization. Conversely, retinas from Envigo pups showed decreased necrosis and increased focal adhesion kinase signaling, supporting more normal vascular development. Comparing oxygen-induced retinopathy transcriptomes at P15 to those at P20, canonical pathways such as phosphate and tensin homolog, interferon, and coordinated lysosomal expression and regulation element signaling were identified, highlighting potential novel mechanistic targets for future research. ConclusionTranscriptomic profiles differ substantially between rat pup retinas from Charles River Laboratories and Envigo at baseline and in response to oxygen-induced retinopathy, providing insight into vascular morphologic differences. Comparing transcriptomes identified new pathways for further research in oxygen-induced retinopathy pathogenesis and increased scientific rigor of this model.


  • Open Access

    Identification of reference genes for the normalization of retinal mRNA expression by RT-qPCR in oxygen induced retinopathy, anemia, and erythropoietin administration

    by Mandkhai Molomjamts, Ellen C Ingolfsland

    Background: Anemia and retinopathy of prematurity (ROP) are common comorbidities experienced by preterm infants, yet the role of anemia on the pathogenesis of ROP remains unclear. Reverse-transcriptase quantitative polymerase chain reaction (RT-qPCR) is a sensitive technique for estimating the gene expression changes at the transcript level but requires identification of stably expressed reference genes for accurate data interpretation. This is particularly important for oxygen induced retinopathy studies given that some commonly used reference genes are sensitive to oxygen. This study aimed to identify stably expressed reference genes among eight commonly used reference genes in the neonatal rat pups’ retina upon exposure to cyclic hyperoxia-hypoxia, anemia, and erythropoietin administration at two age groups (P14.5 and P20) using Bestkeeper, geNorm, and Normfinder, three publicly available, free algorithms, and comparing their results to the in-silico prediction program, RefFinder. Results: The most stable reference gene across both developmental stages was Rpp30, as predicted by Genorm, Bestkeeper, and Normfinder. RefFinder predicted Tbp to be the most stable across both developmental stages. At P14.5, stability varied by prediction program; at P20, RPP30 and MAPK1 were the most stable reference genes. Gapdh, 18S, Rplp0, and HPRT were predicted as the least stable reference genes by at least one of the prediction algorithms. Conclusion: Expression of Rpp30 is the least affected by experimental conditions of oxygen induced retinopathy, phlebotomy induced anemia and erythropoietin administration at both timepoints of P14.5 and P20.


  • Open Access

    Modifiable Risk Factors and Preventative Strategies for Severe Retinopathy of Prematurity

    by Minali Prasad, Ellen C. Ingolfsland, Stephen P. Christiansen

    Severe ROP is characterized by the development of retinal fibrovascular proliferation that may progress to retinal detachment. The purpose of this report is to review five of the most common and well-studied perinatal and neonatal modifiable risk factors for the development of severe ROP. Hyperoxemia, hypoxia, and associated prolonged respiratory support are linked to the development of severe ROP. While there is a well-established association between clinical maternal chorioamnionitis and severe ROP, there is greater variability between histologic chorioamnionitis and severe ROP. Neonatal sepsis, including both bacterial and fungal subtypes, are independent predictors of severe ROP in preterm infants. Although there is limited evidence related to platelet transfusions, the risk of severe ROP increases with the number and volume of red blood cell transfusions. Poor postnatal weight gain within the first six weeks of life is also strongly tied to the development of severe ROP. We also discuss preventative strategies that may reduce the risk of severe ROP. Limited evidence-based studies exist regarding the protective effects of caffeine, human milk, and vitamins A and E.


  • Identification of clinical factors associated with timing and duration of spontaneous regression of retinopathy of prematurity not requiring treatment

    by Jamee Schoephoerster, Sydney Roston, Scott Lunos, Sara E. Ramel, Jill Anderson, Michael K. Georgieff, Ellen C. Ingolfsland

    Objective Identify clinical factors that delay or prolong spontaneous regression of retinopathy of prematurity (ROP). Study design Secondary analysis of three prospective studies with 76 infants with ROP not requiring treatment, born ≤30 weeks postmenstrual age (PMA) and ≤1500 grams. Outcomes were PMA at greatest severity of ROP (PMA MSROP), at which regression began, at time of complete vascularization (PMA CV), and regression duration. Pearson’s correlation coefficients, t-tests, or analyses of variance were calculated. Results Increased positive bacterial cultures, hyperglycemia, transfusion volume of platelets and red blood cells and severity of ROP were associated with later PMA MSROP. Positive bacterial cultures, maternal chorioamnionitis, and less iron deficiency were associated with later PMA CV and prolonged regression duration. Slower length gain was associated with later PMA CV. P < 0.05 for all. Conclusions Preterm infants with inflammatory exposures or linear growth impairment may require longer surveillance for ROP resolution and complete vascularization.


  • Open Access

    Correction: Improving management of ventilator associated tracheitis in a level IV NICU

    by Ellen C. Ingolfsland, Juan David Gonzalez-Villamizar, Jeanne Moore, Janet Kubly, Hawa M. Ali, Ann Kvant, Betsy Smith, Laura Norton

  • Improving management of ventilator associated tracheitis in a level IV NICU

    by Ellen C. Ingolfsland, Juan David Gonzalez-Villamizar, Jeanne Moore, Janet Kubly, Hawa M. Ali, Ann Kvant, Betsy Smith, Laura Norton

    Background There are no published guidelines regarding the diagnosis and treatment of ventilator-associated tracheitis (VAT) in the neonatal intensive care unit (NICU). VAT is likely over-diagnosed and over-treated, increasing antibiotic burden and cost. Local problem Diagnosis and treatment of VAT were entirely NICU provider dependent. Methods Retrospective pre- and post-intervention chart reviews were performed. Interventions A VAT diagnosis and treatment algorithm was created for use in the care of intubated patients without tracheostomies. 3 plan-do-study-act (PDSA) cycles were used to implement change. Results Intubated patients treated for VAT with 7 days of antibiotic therapy decreased from 42% to 10%. Conclusion Implementing a QI initiative to improve the diagnosis and treatment of VAT in the NICU decreased the percent of patients treated inappropriately for VAT.